121 related articles for article (PubMed ID: 2594612)
1. Steady-state serum concentrations of imipramine, its main metabolites and clinical response in primary enuresis.
Furlanut M; Montanari G; Benetello P; Bonin P; Schiaulini P; Pellegrino PA
Pharmacol Res; 1989; 21(5):561-6. PubMed ID: 2594612
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children.
de Gatta MF; García MJ; Acosta A; Rey F; Gutierrez JR; Dominguez-Gil A
Ther Drug Monit; 1984; 6(4):438-43. PubMed ID: 6515703
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentration and clinical effect in imipramine treatment of childhood enuresis.
Jorgensen OS; Lober M; Christiansen J; Gram LF
Clin Pharmacokinet; 1980; 5(4):386-93. PubMed ID: 6994982
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels and efficacy of imipramine treatment for enuresis.
Fritz GK; Rockney RM; Yeung AS
J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):60-4. PubMed ID: 8138522
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of imipramine and its metabolites during enuresis therapy.
DeVane CL; Walker RD; Sawyer WP; Wilson JA
Pediatr Pharmacol (New York); 1984; 4(4):245-51. PubMed ID: 6522133
[TBL] [Abstract][Full Text] [Related]
6. The influence of clinical and pharmacological factors on enuresis treatment with imipramine.
Fernández de Gatta MM; Galindo P; Rey F; Gutierrez J; Tamayo M; García MJ; Domínguez-Gil A
Br J Clin Pharmacol; 1990 Nov; 30(5):693-8. PubMed ID: 2271368
[TBL] [Abstract][Full Text] [Related]
7. Active metabolites of imipramine and desipramine in man.
Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of imipramine in children.
Tamayo M; Fernández de Gatta MM; García MJ; Domínguez-Gil A
Eur J Clin Pharmacol; 1992; 43(1):89-92. PubMed ID: 1505617
[TBL] [Abstract][Full Text] [Related]
9. Childhood enuresis. II. Psychopathology, tricyclic concentration in plasma, and antienuretic effect.
Rapoport JL; Mikkelsen EJ; Zavadil A; Nee L; Gruenau C; Mendelson W; Gillin JC
Arch Gen Psychiatry; 1980 Oct; 37(10):1146-52. PubMed ID: 7000030
[TBL] [Abstract][Full Text] [Related]
10. Targeting imipramine dose in children with depression.
Sallee F; Stiller R; Perel J; Rancurello M
Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
[TBL] [Abstract][Full Text] [Related]
11. Dosage optimization methods applied to imipramine and desipramine in enuresis treatment.
Tamayo M; Fernández de Gatta MM; García MJ; Domínguez-Gil A
J Clin Pharm Ther; 1992 Feb; 17(1):55-9. PubMed ID: 1548314
[TBL] [Abstract][Full Text] [Related]
12. Prediction of imipramine serum levels in enuretic children by a Bayesian method: comparison with two other conventional dosing methods.
Fernández de Gatta MM; Tamayo M; García MJ; Amador D; Rey F; Gutiérrez JR; Domínguez-Gil Hurlé A
Ther Drug Monit; 1989 Nov; 11(6):637-41. PubMed ID: 2595743
[TBL] [Abstract][Full Text] [Related]
13. Imipramine in primary nocturnal enuresis and the value of blood level measurements.
Manglick MP; Buchanan N
Med J Aust; 1992 Jan; 156(1):68-9. PubMed ID: 1734202
[No Abstract] [Full Text] [Related]
14. Imipramine for therapy resistant enuresis: a retrospective evaluation.
Gepertz S; Nevéus T
J Urol; 2004 Jun; 171(6 Pt 2):2607-10; discussion 2609-10. PubMed ID: 15118430
[TBL] [Abstract][Full Text] [Related]
15. Hypnosis and self-hypnosis in the management of nocturnal enuresis: a comparative study with imipramine therapy.
Banerjee S; Srivastav A; Palan BM
Am J Clin Hypn; 1993 Oct; 36(2):113-9. PubMed ID: 8259762
[TBL] [Abstract][Full Text] [Related]
16. Model for the kinetics of imipramine and its metabolites in adolescents.
Dell RB; Hein K; Ramakrishnan R; Puig-Antich J; Cooper T
Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407
[TBL] [Abstract][Full Text] [Related]
17. "Enuresis risoria": evaluation and management.
Arena MG; Leggiadro N; Arcudi L; Ruello C; D'Amico D; Deodato M; Meduri M
Funct Neurol; 1987; 2(4):579-82. PubMed ID: 3443384
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
Tahmaz L; Kibar Y; Yildirim I; Ceylan S; Dayanç M
Urol Int; 2000; 65(3):135-9. PubMed ID: 11054030
[TBL] [Abstract][Full Text] [Related]
19. Combined pharmacotherapy for nocturnal enuresis.
Kaneko K; Fujinaga S; Ohtomo Y; Shimizu T; Yamashiro Y
Pediatr Nephrol; 2001 Aug; 16(8):662-4. PubMed ID: 11519898
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of imipramine in enuresis nocturna.
Korczyn AD; Kish I
Clin Exp Pharmacol Physiol; 1979; 6(1):31-5. PubMed ID: 367655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
